These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14670642)

  • 21. Oestrogen and vascular disease.
    Harvey P
    Aust N Z J Med; 1999 Jun; 29(3):473-9. PubMed ID: 10868522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex hormones and cardiovascular risk.
    L'Hermite M
    Acta Cardiol; 1991; 46(3):357-72. PubMed ID: 1927164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.
    Mijatovic V; van der Mooren MJ; Stehouwer CD; Netelenbos JC; Kenemans P
    Gynecol Endocrinol; 1999 Apr; 13(2):130-44. PubMed ID: 10399059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin.
    Lindheim SR; Presser SC; Ditkoff EC; Vijod MA; Stanczyk FZ; Lobo RA
    Fertil Steril; 1993 Oct; 60(4):664-7. PubMed ID: 8405521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute vascular effects of estrogen in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Circulation; 1994 Aug; 90(2):786-91. PubMed ID: 8044949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progestins and cardiovascular risk markers.
    Sitruk-Ware R
    Steroids; 2000; 65(10-11):651-8. PubMed ID: 11108872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
    Lee SJ; Lee DW; Kim KS; Lee IK
    Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New progestogens: a review of their effects in perimenopausal and postmenopausal women.
    Sitruk-Ware R
    Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Jan; 35(1):1-16. PubMed ID: 7751408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioprotective effects of ovarian hormones and the HERS in perspective.
    Rosano GM; Graziottin A; Fini M
    Maturitas; 2000 Apr; 34 Suppl 2():S3-10. PubMed ID: 10915917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular effects and estrogen/gestagen substitution therapy].
    Kuhl H
    Ther Umsch; 1994 Nov; 51(11):748-54. PubMed ID: 7839333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study.
    Fineberg SE
    Drugs Aging; 2000 Dec; 17(6):453-61. PubMed ID: 11200306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks of estrogens and progestogens.
    L'Hermite M
    Maturitas; 1990 Sep; 12(3):215-46. PubMed ID: 2170823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen replacement and brachial artery flow-mediated vasodilation in older women.
    Herrington DM; Espeland MA; Crouse JR; Robertson J; Riley WA; McBurnie MA; Burke GL
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1955-61. PubMed ID: 11742870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Mar; 35(3):314-29. PubMed ID: 7608324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.